Logo image of ALCC

ALTC ACQUISITION CORP-CL A (ALCC) Stock Fundamental Analysis

NYSE:ALCC - New York Stock Exchange, Inc. - US02156V1098 - Common Stock - Currency: USD

18.23  +3.06 (+20.17%)

After market: 17.94 -0.29 (-1.59%)

Fundamental Rating

2

Taking everything into account, ALCC scores 2 out of 10 in our fundamental rating. ALCC was compared to 0 industry peers in the Unkown industry. ALCC scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. ALCC does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

ALCC had positive earnings in the past year.
ALCC had a negative operating cash flow in the past year.
ALCC Yearly Net Income VS EBIT VS OCF VS FCFALCC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 0 5M -5M 10M -10M

1.2 Ratios

Industry RankSector Rank
ROA 3.88%
ROE 4.02%
ROIC N/A
ROA(3y)1.48%
ROA(5y)N/A
ROE(3y)1.54%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALCC Yearly ROA, ROE, ROICALCC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 1 -1 2 3 4

1.3 Margins

ALCC does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ALCC Yearly Profit, Operating, Gross MarginsALCC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023

More info and screens

5

2. Health

2.1 Basic Checks

The number of shares outstanding for ALCC remains at a similar level compared to 1 year ago.
ALCC has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
ALCC Yearly Shares OutstandingALCC Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 20M 40M 60M
ALCC Yearly Total Debt VS Total AssetsALCC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 100M 200M 300M 400M 500M

2.2 Solvency

ALCC has an Altman-Z score of 44.42. This indicates that ALCC is financially healthy and has little risk of bankruptcy at the moment.
ALCC has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 44.42
ROIC/WACCN/A
WACCN/A
ALCC Yearly LT Debt VS Equity VS FCFALCC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 100M 200M 300M 400M

2.3 Liquidity

ALCC has a Current Ratio of 0.59. This is a bad value and indicates that ALCC is not financially healthy enough and could expect problems in meeting its short term obligations.
A Quick Ratio of 0.59 indicates that ALCC may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.59
Quick Ratio 0.59
ALCC Yearly Current Assets VS Current LiabilitesALCC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 1M 2M 3M 4M

More info and screens

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 308.58% over the past year.
EPS 1Y (TTM)308.58%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%41.18%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 91.15 indicates a quite expensive valuation of ALCC.
Compared to an average S&P500 Price/Earnings ratio of 27.91, ALCC is valued quite expensively.
Industry RankSector Rank
PE 91.15
Fwd PE N/A
ALCC Price Earnings VS Forward Price EarningsALCC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALCC Per share dataALCC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ALCC!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ALTC ACQUISITION CORP-CL A

NYSE:ALCC (5/9/2024, 8:04:00 PM)

After market: 17.94 -0.29 (-1.59%)

18.23

+3.06 (+20.17%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)05-13 2024-05-13
Earnings (Next)08-09 2024-08-09
Inst Owners107.54%
Inst Owner Change1.57%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap785.71M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 91.15
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 2.66
P/tB 2.66
EV/EBITDA N/A
EPS(TTM)0.2
EY1.1%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.25
FCFYN/A
OCF(TTM)-0.25
OCFYN/A
SpS0
BVpS6.85
TBVpS6.85
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.88%
ROE 4.02%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)1.48%
ROA(5y)N/A
ROE(3y)1.54%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.59
Quick Ratio 0.59
Altman-Z 44.42
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)308.58%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%41.18%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-136.01%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-1041.54%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1041.54%
OCF growth 3YN/A
OCF growth 5YN/A